Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

de Boer Daniel Anton — ProQR Therapeutics N.V. insider · InsiderLens

Home / Insiders / de Boer Daniel Anton

de Boer Daniel Anton

Director at ProQR Therapeutics N.V. · on record since Mar 18, 2026
Chief Executive Officer at ProQR Therapeutics N.V. · on record since Mar 18, 2026

Insider trading activity of de Boer Daniel Anton

No transactions on record for de Boer Daniel Anton.

Track record of de Boer Daniel Anton

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of de Boer Daniel Anton

Co-insiders of de Boer Daniel Anton

Carreno-Gomez BegonaProQR Therapeutics N.V.
Filius BartProQR Therapeutics N.V.
HEGGIE THERESAProQR Therapeutics N.V.
Hinsch Gylvin LykkeProQR Therapeutics N.V.
Hom DennisProQR Therapeutics N.V.
LAWTON ALISON FRANCISProQR Therapeutics N.V.
Maier Martin AlexanderProQR Therapeutics N.V.
Platenburg Gerardus JohannesProQR Therapeutics N.V.
Shannon James SamuelProQR Therapeutics N.V.
Valerio DomenicoProQR Therapeutics N.V.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters